Layer 1

What's next for the Parkinson's MUR?

(Left to right): North-west London LPF lead Stephanie Bancroft; clinical editor Kristoffer Stewart; pharmacist Christopher Glass
(Left to right): North-west London LPF lead Stephanie Bancroft; clinical editor Kristoffer Stewart; pharmacist Christopher Glass

C+D spoke to Stephanie Bancroft to discuss the progress of Parkinson's-specific medicines use review (MUR).

Ms Bancroft, community pharmacist and Royal Pharmaceutical Society local pharmacy forum lead for north-west London, has been working on a joint project with Parkinson's UK to introduce a Parkinson's disease-specific MUR.

The MUR toolkit was originally tested on 32 Parkinson's patients in 2016, before being rolled out to 29 pharmacists "from all over the UK", Ms Bancroft told C+D.

Watch the video to find out:

  • How the Parkinson's-specific MUR was created
  • The accreditation pharmacists undertake to enable them to deliver the service
  • The difference it made to one pharmacist, Christopher Glass, in his ability to perform an effective MUR
  • How Mr Glass has been working with his local GP to help them review patients with Parkinson's disease
  • The next steps for this project, including working with care homes and practice pharmacists.

View the full video below:

2 Comments

Valentine Trodd, Community pharmacist

More MURs? No thanks...

James Mac, Community pharmacist

Its on shaky ground. It's a bit like the ED service- a total flop! Nobody came.

Job of the week

Community Pharmacist - Tier 2 provided
South East England, Oxfordshire
Up to £40k per annum - negotiable


Have your say

Do you think the prescription charge should be scrapped in England?